What did Platinum Equity pay for LifeScan (J&J)?

Platinum Equity acquired LifeScan (J&J) for $2.10B in 2018, equivalent to 1.40x revenue. Target revenue was approximately $1500.0M.

What does LifeScan (J&J) do?

LifeScan (J&J) is a medical devices business.

What multiple did Platinum Equity pay for LifeScan (J&J)?

1.40x revenue, based on disclosed deal value of $2.10B and disclosed financials.

M&A TRANSACTION · 2018

LifeScan (J&J) acquired by Platinum Equity

$2.10B· 1.40x revenue

Target

LifeScan (J&J)

Acquirer

Platinum Equity

Private Equity buyer

Disclosed financials at time of acquisition

Revenue

$1500.0M

EBITDA

—

Deal Value

$2.10B

EV/EBITDA

—

Context

This $2.10B acquisition of LifeScan (J&J) by Platinum Equity sits in the medical devices sub-vertical. Platinum Equity is acquiring as a private equity buyer; see how PE acquirers typically price medical devices businesses on our Medical Devices PE buyer-pool page.

Source

Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the LifeScan (J&J) acquisition.

Citation: ExitValue.ai. (2018). LifeScan (J&J) acquired by Platinum Equity. https://exitvalue.ai/deals/lifescan-jj-acquired-by-platinum-equity-hc-2018-0163